Literature DB >> 24467240

Proposing advancement criteria for efficient DMPK triage of new chemical entities.

Ashutosh Kulkarni1, Jennifer Riggs, Cindy Phan, April Bai, Andrew Calabrese, Tao Shi, Mehran F Moghaddam.   

Abstract

With the goal of refining our discovery DMPK workflow, we conducted a retrospective analysis on internal Celgene compounds by calculating the physicochemical properties and gathering data from several assays including solubility, rat and human liver S9 stability, Caco-2 permeability, and rat intravenous (iv.) and oral pharmacokinetics. Our analysis identified plasma clearance to be most statistically relevant for prediction of oral exposure. In rat, compounds with rat S9 stability of ≥70% at 60 min and a plasma clearance of ≤43 ml/min/kg had the greatest chance of achieving oral exposures above 3 µM.h. Compounds with the dual advantage of plasma clearance ≤43 ml/min/kg and Caco-2 permeability ≥8 × 10(-6) cm/s or efflux ratio ≤8 were highly likely to achieve those oral exposures. Implementation of these criteria leads to a significant increase in efficiency, good pharmacokinetic properties, cost savings and a reduction in the use of animals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24467240     DOI: 10.4155/fmc.13.190

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  3 in total

Review 1.  A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015.

Authors:  Zhihong O Brien; Mehran F Moghaddam
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

2.  Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability.

Authors:  Samantha J Richardson; April Bai; Ashutosh A Kulkarni; Mehran F Moghaddam
Journal:  Drug Metab Lett       Date:  2016

3.  Formation of A Novel Purine Metabolite through CYP3A4 Bioactivation and Glutathione Conjugation.

Authors:  Julius L Apuy; Cathie Xiang; Sarah Franc; Sayee G Hegde; Robert Hubbard; Jingjing Zhao; Mehran F Moghaddam
Journal:  Drug Metab Lett       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.